Form 4: Alignment Healthcare Officer Sells Shares for Tax
Insider Transaction Report
Alignment Healthcare's Chief Legal and Admin. Officer, Christopher J. Joyce, sold 16,187 shares of common stock to cover tax withholding obligations related to performance share unit vesting.
Summary
- Christopher J. Joyce, Chief Legal and Admin. Officer of Alignment Healthcare, Inc. (ALHC), sold a total of 16,187 shares of common stock.
- The sales occurred on December 29, 2025.
- These transactions were non-discretionary, executed solely to cover tax withholding obligations associated with the vesting of performance share units.
- The first sale involved 15,299 shares at a weighted-average price of $18.7056 per share, with prices ranging from $18.23 to $19.225.
- The second sale involved 888 shares at a weighted-average price of $19.3818 per share, with prices ranging from $19.23 to $19.51.
- Following these transactions, Mr. Joyce beneficially owns 307,699 shares of Alignment Healthcare common stock.
- The transactions were made pursuant to a Rule 10b5-1(c) plan.
Sentiment
Score: 5
Explanation: Neutral. The transaction is a routine, non-discretionary sale to cover tax obligations from vested equity, not indicative of management's sentiment towards the company's future performance.
Positives
- The sale was non-discretionary, indicating it was not a voluntary divestment based on a negative outlook.
- The vesting of performance share units implies the achievement of certain performance targets by the company or the executive.
Negatives
- A reduction in the beneficial ownership of common stock by a key officer, even if for tax purposes.
Future Outlook
NA
Industry Context
This is a routine insider transaction for tax purposes, common across all industries when executives receive equity compensation. It does not reflect specific industry trends for healthcare.
Comparison to Industry Standards
- This is a standard practice for executives to sell shares to cover tax obligations upon the vesting of equity awards. It aligns with typical compensation structures and tax requirements seen in publicly traded companies across various sectors, including healthcare. No specific comparable companies or projects are relevant for this type of filing.
Stakeholder Impact
- Shareholders: Minor, as the sale is non-discretionary and for tax purposes, not a signal of lack of confidence. It slightly reduces insider ownership.
- Employees: No direct impact.
- Customers: No direct impact.
- Suppliers: No direct impact.
- Creditors: No direct impact.
Key Dates
| Date | Description |
|---|---|
| 12/29/2025 | Date of transaction for common stock sales. |
| 12/30/2025 | Date of signature for the filing. |
Recommendation
holdThis Form 4 filing details a routine, non-discretionary sale of shares by an executive to cover tax withholding obligations upon the vesting of performance share units. Such transactions are common and do not typically reflect a change in the executive's outlook on the company's fundamentals or future prospects. Therefore, it provides no new information that would warrant a change in investment recommendation. Investors should hold their position and focus on the company's operational performance and strategic announcements.
Keywords
Alignment Healthcare, ALHC, Form 4, Insider Trading, Stock Sale, Tax Withholding, Performance Share Units, Executive Compensation, Christopher J. Joyce
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.